雷马佐拉姆在危急疾病中的安全性和有效性
Shinju Obara1, Keisuke Yoshida2, Satoki Inoue2
1Department of Anesthesiology, Fukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan. obashin99@gmail.com.
雷米马佐拉姆是一种新型超短效镇静剂,比传统的重症监护室 (ICU) 镇静剂具有相似的疗效和更好的血液动力稳定性. 其可预测的恢复概况可能有利于重症患者,但需要进一步研究.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 麻醉学 麻醉学
背景情况:
- 镇静在ICU中至关重要,但当前的药物会导致血液动力学不稳定,延迟恢复和妄想.
- 雷米马佐拉姆是一种超短效的二,提供快速的新陈代谢和可预测的恢复,对重症监护镇静有潜在的好处.
研究的目的:
- 审查雷米马佐拉姆在重症监护室 (ICU) 设置中的疗效,安全性和恢复概况.
- 为了比较雷米马佐拉姆与常规镇静剂,用于需要机械通风的ICU患者.
主要方法:
- 随机对照试验,元分析和观察性研究的叙事综述.
- 关于雷马佐拉姆的疗效,安全性,血液动力学耐受性以及对狂妄和恢复的影响的综合证据.
主要成果:
- 雷米马佐拉姆在各种环境中表现出与常规催眠药相当的镇静效果.
- 与普罗波福尔或米达佐拉姆相比,血液动力学耐受性良好,狂妄发作率没有增加.
- 在机械通风ICU患者中,安全性和疗效相似,血液动力学稳定性可接受.
结论:
- 雷米马佐拉姆是重症患者有前途的镇静剂,可预测的恢复和有利的血液动力学.
- 需要进一步进行高质量的国际多中心研究,以确认其在长期机械通风和神经认知结果中的最佳作用.
更多相关视频
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
相关概念视频
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Concepts of Health and Illness
Dimensions of Health and Illness
Survey Safety
Critical Region, Critical Values and Significance Level
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
